ArticleInternational journal of urology : official journal of the Japanese Urological Association2022

Presence of CD133-positive circulating tumor cells predicts worse progression-free survival in patients with metastatic castration-sensitive prostate cancer.

Yunjie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.